Skip to main content

Table 4 Changes from baseline to 6-month visit in control group

From: Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study

  Baseline 6-month Δ from baseline p
Indexed LVM (g/m2) 90.8 ± 21.0 88.5 ± 22.5 − 2.3 ± 4.1 0.58
LV end-diastolic volume (ml) 97.0 ± 25.7 96.2 ± 26.2 − 0.8 ± 4.7 0.86
LV end-diastolic diameter (mm) 44.5 ± 4.3 45.0 ± 4.2 0.4 ± 0.8 0.57
LV ejection fraction (%) 64.6 ± 5.8 64.4 ± 4.6 − 0.2 ± 1.3 0.89
RWT 0.49 ± 0.08 0.47 ± 0.10 − 0.02 ± 0.02 0.35
GLS − 19.6 ± 2.5 − 20.0 ± 2.4 − 0.4 ± 0.6 0.34
LA indexed volume (ml/m2) 28.7 ± 9.1 28.9 ± 8.5 0.3 ± 1.4 0.85
E/A ratio 0.81 ± 0.26 0.73 ± 0.20 − 0.08 ± 0.04 0.05
Lateral e’ (cm/s) 8.26 ± 3.24 8.35 ± 2.35 0.09 ± 0.73 0.90
Septal e’ (cm/s) 5.78 ± 1.22 5.95 ± 1.26 0.16 ± 0.23 0.48
E/e’ ratio 9.79 ± 2.44 9.10 ± 2.36 − 0.69 ± 0.68 0.32
  1. LVM left ventricular mass, LV left ventricular, RWT relative wall thickness, GLS global longitudinal strain, LA left atrial